Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hellmann

Showing results (131-140 of 196) with videos related to

Pageof 20
Sort By:
The Israel Medical Association Journal : IMAJ|July 31, 2024
Applicability of the New Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease Diagnostic Criteria in an Israeli CohortAviv Fineberg, Itay Lotan, Omer Bialer, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 5, 2011
Experience with Optivate®, a new high purity concentrate of factor VIII with von Willebrand factor, in patients undergoing surgeryC R M Hay, A Hellmann, A Dmoszynska, et al.
Antimicrobial Agents and Chemotherapy|September 19, 2000
A pharmacokinetic study of amphotericin B lipid complex injection (Abelcet) in patients with definite or probable systemic fungal infectionsA Adedoyin, C E Swenson, L E Bolcsak, et al.
Plant & Cell Physiology|October 9, 2020
Aspartate Residues in a Forisome-Forming SEO Protein Are Critical for Protein Body Assembly and Ca2+ ResponsivenessYan Liu, Winfried S Peters, Daniel R Froelich, et al.
Journal of the Neurological Sciences|July 9, 2014
Tumefactive demyelination and a malignant course in an MS patient during and following fingolimod therapyM A Hellmann, N Lev, I Lotan, et al.
Haematologica|April 28, 2001
Thalidomide treatment of resistant or relapsed multiple myeloma patientsM Hus, A Dmoszynska, M Soroka-Wojtaszko, et al.
Pneumologie (Stuttgart, Germany)|March 4, 2016
[Cannabis--Position Paper of the German Respiratory Society (DGP)]M Kreuter, D Nowak, T Rüther, et al.
Immunology and Cell Biology|December 11, 2020
Alemtuzumab mediates the CD39<sup>+</sup> T-regulatory cell response via CD23<sup>+</sup> macrophagesLital Remez, Esther Ganelin-Cohen, Dina Safina, et al.
Acta Haematologica Polonica|July 1, 1988
[Human recombinant alfa-2 interferon in the treatment of hairy cell leukemia]T Wolska-Smoleń, A B Skotnicki, J Blicharski, et al.
Multiple Sclerosis and Related Disorders|June 30, 2020
Saliva immunoglobulin free light chain analysis for monitoring disease activity and response to treatment in multiple sclerosisItay Lotan, Esther Ganelin-Cohen, Evgeny Tartakovsky, et al.
Pageof 20

Showing results (131-140 of 196) with videos related to

Sort By:
Pageof 20
The Israel Medical Association Journal : IMAJ|July 31, 2024
Applicability of the New Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease Diagnostic Criteria in an Israeli CohortAviv Fineberg, Itay Lotan, Omer Bialer, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 5, 2011
Experience with Optivate®, a new high purity concentrate of factor VIII with von Willebrand factor, in patients undergoing surgeryC R M Hay, A Hellmann, A Dmoszynska, et al.
Antimicrobial Agents and Chemotherapy|September 19, 2000
A pharmacokinetic study of amphotericin B lipid complex injection (Abelcet) in patients with definite or probable systemic fungal infectionsA Adedoyin, C E Swenson, L E Bolcsak, et al.
Plant & Cell Physiology|October 9, 2020
Aspartate Residues in a Forisome-Forming SEO Protein Are Critical for Protein Body Assembly and Ca2+ ResponsivenessYan Liu, Winfried S Peters, Daniel R Froelich, et al.
Journal of the Neurological Sciences|July 9, 2014
Tumefactive demyelination and a malignant course in an MS patient during and following fingolimod therapyM A Hellmann, N Lev, I Lotan, et al.
Haematologica|April 28, 2001
Thalidomide treatment of resistant or relapsed multiple myeloma patientsM Hus, A Dmoszynska, M Soroka-Wojtaszko, et al.
Pneumologie (Stuttgart, Germany)|March 4, 2016
[Cannabis--Position Paper of the German Respiratory Society (DGP)]M Kreuter, D Nowak, T Rüther, et al.
Immunology and Cell Biology|December 11, 2020
Alemtuzumab mediates the CD39<sup>+</sup> T-regulatory cell response via CD23<sup>+</sup> macrophagesLital Remez, Esther Ganelin-Cohen, Dina Safina, et al.
Acta Haematologica Polonica|July 1, 1988
[Human recombinant alfa-2 interferon in the treatment of hairy cell leukemia]T Wolska-Smoleń, A B Skotnicki, J Blicharski, et al.
Multiple Sclerosis and Related Disorders|June 30, 2020
Saliva immunoglobulin free light chain analysis for monitoring disease activity and response to treatment in multiple sclerosisItay Lotan, Esther Ganelin-Cohen, Evgeny Tartakovsky, et al.
Pageof 20